Introducing iron isomaltoside 1000 (Monofer®)—development rationale and clinical experience

por Kalra, Philip A.
Publicado en NDT Plus (2011)

Clinical management of atheromatous renovascular disease

por Kalra, Philip A
Publicado en Clin Med (Lond) (2009)

Efficacy and safety of iron isomaltoside (Monofer(®)) in the management of patients with iron deficiency anemia

por Kalra, Philip A, Bhandari, Sunil
Publicado en Int J Nephrol Renovasc Dis (2016)

Safety of intravenous iron use in chronic kidney disease

por Kalra, Philip A., Bhandari, Sunil
Publicado en Curr Opin Nephrol Hypertens (2016)

Atherosclerotic renovascular disease – epidemiology, treatment and current challenges

por Vassallo, Diana, Kalra, Philip A.
Publicado en Postepy Kardiol Interwencyjnej (2017)

A validation study of the 4-variable and 8-variable kidney failure risk equation in transplant recipients in the United Kingdom

por Ali, Ibrahim, Kalra, Philip A.
Publicado en BMC Nephrol (2021)

Comparison of impact on death and critical care admission of acute kidney injury between common medical and surgical diagnoses

por Sykes, Lynne, Kalra, Philip A., Green, Darren
Publicado en PLoS One (2019)

Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis

por Chinnadurai, Rajkumar, Flanagan, Emma, Kalra, Philip A.
Publicado en J Nephrol (2019)

SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England

por Poulikakos, Dimitrios, Sinha, Smeeta, Kalra, Philip A.
Publicado en J Clin Virol (2020)

A narrative review of the impact of interventions in acute kidney injury

por Sykes, Lynne, Nipah, Rob, Kalra, Philip, Green, Darren
Publicado en J Nephrol (2017)

Treatment of anaemia in end-stage renal disease: A double-edged iron sword?

por Chinnadurai, Rajkumar, Macdougall, Iain C., Kalra, Philip A.
Publicado en EBioMedicine (2019)

Is it time to relax nephrogenic systemic fibrosis guidelines and safely offer magnetic resonance imaging to more patients?

por Al-Chalabi, Saif, Chrysochou, Constantina, Kalra, Philip A.
Publicado en Quant Imaging Med Surg (2019)

Associations of urological malignancies with renal progression and mortality in advanced chronic kidney disease: a propensity-matched cohort study

por Chinnadurai, Rajkumar, Clarke, Noel W., Kalra, Philip A.
Publicado en BMC Nephrol (2020)

A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical...

por Ali, Ibrahim, Donne, Rosemary L., Kalra, Philip A.
Publicado en BMC Nephrol (2021)

Revascularization as a treatment to improve renal function

por Alderson, Helen V, Ritchie, James P, Kalra, Philip A
Publicado 2014

Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression

por Ali, Ibrahim, Chinnadurai, Rajkumar, Ibrahim, Sara T., Kalra, Philip A.
Publicado en BMC Nephrol (2021)

Cognitive impairment in patients with moderate to severe chronic kidney disease: the Salford kidney cohort study

por Tollitt, James, Odudu, Aghogho, Montaldi, Daniela, Kalra, Philip A
Publicado en Clin Kidney J (2020)

Diabetic kidney disease: update on clinical management and non-glycaemic effects of newer medications for type 2 diabetes

por de Bhailís, Áine M., Azmi, Shazli, Kalra, Philip A.
Publicado en Ther Adv Endocrinol Metab (2021)

Inflammation and Oxidative Damage in Ischaemic Renal Disease

por de Bhailís, Áine M., Chrysochou, Constantina, Kalra, Philip A.
Publicado en Antioxidants (Basel) (2021)

Estimating renal function in old people: an in-depth review

por Raman, Maharajan, Middleton, Rachel J., Kalra, Philip A., Green, Darren
Publicado en Int Urol Nephrol (2017)